Global Lipid Contract Manufacturing Market Research Report 2023

Publication ID:

PB501234705

Publication Date:

January 10, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Liposomes and lipid nanoparticles (LNPs) are similar by design, but slightly different in composition and function. Both are lipid nanoformulations and excellent drug delivery vehicles, transporting cargo of interest within a protective, outer layer of lipids. In application, however, LNPs can take a variety of forms.Innovators in the biopharmaceutical industry have developed a number of ways to improve/augment physiochemical properties and ultimately, the drug-like behavior of pharmacological substances. Amidst other alternatives, lipid nanoparticles and liposomes are the main type.Nanoparticle Drug Delivery Systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.Liposomes and Lipid Nanoparticles are delivery carriers, the primary lipids used to make liposomes or Lipid Nanoparticles are Phospholipids, Pegylated Lipids, Ionizable Lipids (Cationic / Anionic Lipids), Triglycerides, Sphingolipids, Neutral Lipids, etc. In our report, we mainly study the Liposomes and Lipid Nanoparticles (LNP) Contract Manufacturing as delivery carriers.
Highlights
The global Lipid Contract Manufacturing market was valued at US$ 831.7 million in 2022 and is anticipated to reach US$ 783.5 million by 2029, witnessing a CAGR of -1.0% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core lipid contract manufacturing companies include Merck KGaA, Exelead and Avanti Polar Lipids etc. The top 3 companies hold a share about 38%. North America is the largest market, with a share over 60%, followed by Europe and APAC with the share about 26% and 12%.
In terms of product, lipid nanoparticles is the largest segment with a share about 79%. And in terms of application, the largest application is commercial with a share about 67%, followed by clinical and preclinical.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Lipid Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lipid Contract Manufacturing.
The Lipid Contract Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Lipid Contract Manufacturing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lipid Contract Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Precision NanoSystems
Evonik
Merck KGaA
Genevant Sciences
Exelead
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid
Polymun Scientific
Corden Pharma
Acuitas Therapeutics
Segment by Type
Liposomes
Lipid Nanoparticles
Segment by Application
Preclinical
Clinical
Commercial
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lipid Contract Manufacturing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lipid Contract Manufacturing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Liposomes
1.2.3 Lipid Nanoparticles
1.3 Market by Application
1.3.1 Global Lipid Contract Manufacturing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Preclinical
1.3.3 Clinical
1.3.4 Commercial
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lipid Contract Manufacturing Market Perspective (2018-2029)
2.2 Lipid Contract Manufacturing Growth Trends by Region
2.2.1 Global Lipid Contract Manufacturing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Lipid Contract Manufacturing Historic Market Size by Region (2018-2023)
2.2.3 Lipid Contract Manufacturing Forecasted Market Size by Region (2024-2029)
2.3 Lipid Contract Manufacturing Market Dynamics
2.3.1 Lipid Contract Manufacturing Industry Trends
2.3.2 Lipid Contract Manufacturing Market Drivers
2.3.3 Lipid Contract Manufacturing Market Challenges
2.3.4 Lipid Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lipid Contract Manufacturing Players by Revenue
3.1.1 Global Top Lipid Contract Manufacturing Players by Revenue (2018-2023)
3.1.2 Global Lipid Contract Manufacturing Revenue Market Share by Players (2018-2023)
3.2 Global Lipid Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lipid Contract Manufacturing Revenue
3.4 Global Lipid Contract Manufacturing Market Concentration Ratio
3.4.1 Global Lipid Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lipid Contract Manufacturing Revenue in 2022
3.5 Lipid Contract Manufacturing Key Players Head office and Area Served
3.6 Key Players Lipid Contract Manufacturing Product Solution and Service
3.7 Date of Enter into Lipid Contract Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lipid Contract Manufacturing Breakdown Data by Type
4.1 Global Lipid Contract Manufacturing Historic Market Size by Type (2018-2023)
4.2 Global Lipid Contract Manufacturing Forecasted Market Size by Type (2024-2029)
5 Lipid Contract Manufacturing Breakdown Data by Application
5.1 Global Lipid Contract Manufacturing Historic Market Size by Application (2018-2023)
5.2 Global Lipid Contract Manufacturing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Lipid Contract Manufacturing Market Size (2018-2029)
6.2 North America Lipid Contract Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Lipid Contract Manufacturing Market Size by Country (2018-2023)
6.4 North America Lipid Contract Manufacturing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lipid Contract Manufacturing Market Size (2018-2029)
7.2 Europe Lipid Contract Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Lipid Contract Manufacturing Market Size by Country (2018-2023)
7.4 Europe Lipid Contract Manufacturing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lipid Contract Manufacturing Market Size (2018-2029)
8.2 Asia-Pacific Lipid Contract Manufacturing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Lipid Contract Manufacturing Market Size by Region (2018-2023)
8.4 Asia-Pacific Lipid Contract Manufacturing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lipid Contract Manufacturing Market Size (2018-2029)
9.2 Latin America Lipid Contract Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Lipid Contract Manufacturing Market Size by Country (2018-2023)
9.4 Latin America Lipid Contract Manufacturing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lipid Contract Manufacturing Market Size (2018-2029)
10.2 Middle East & Africa Lipid Contract Manufacturing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Lipid Contract Manufacturing Market Size by Country (2018-2023)
10.4 Middle East & Africa Lipid Contract Manufacturing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Precision NanoSystems
11.1.1 Precision NanoSystems Company Detail
11.1.2 Precision NanoSystems Business Overview
11.1.3 Precision NanoSystems Lipid Contract Manufacturing Introduction
11.1.4 Precision NanoSystems Revenue in Lipid Contract Manufacturing Business (2018-2023)
11.1.5 Precision NanoSystems Recent Development
11.2 Evonik
11.2.1 Evonik Company Detail
11.2.2 Evonik Business Overview
11.2.3 Evonik Lipid Contract Manufacturing Introduction
11.2.4 Evonik Revenue in Lipid Contract Manufacturing Business (2018-2023)
11.2.5 Evonik Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Detail
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Lipid Contract Manufacturing Introduction
11.3.4 Merck KGaA Revenue in Lipid Contract Manufacturing Business (2018-2023)
11.3.5 Merck KGaA Recent Development
11.4 Genevant Sciences
11.4.1 Genevant Sciences Company Detail
11.4.2 Genevant Sciences Business Overview
11.4.3 Genevant Sciences Lipid Contract Manufacturing Introduction
11.4.4 Genevant Sciences Revenue in Lipid Contract Manufacturing Business (2018-2023)
11.4.5 Genevant Sciences Recent Development
11.5 Exelead
11.5.1 Exelead Company Detail
11.5.2 Exelead Business Overview
11.5.3 Exelead Lipid Contract Manufacturing Introduction
11.5.4 Exelead Revenue in Lipid Contract Manufacturing Business (2018-2023)
11.5.5 Exelead Recent Development
11.6 Avanti Polar Lipids
11.6.1 Avanti Polar Lipids Company Detail
11.6.2 Avanti Polar Lipids Business Overview
11.6.3 Avanti Polar Lipids Lipid Contract Manufacturing Introduction
11.6.4 Avanti Polar Lipids Revenue in Lipid Contract Manufacturing Business (2018-2023)
11.6.5 Avanti Polar Lipids Recent Development
11.7 Nippon Fine Chemical
11.7.1 Nippon Fine Chemical Company Detail
11.7.2 Nippon Fine Chemical Business Overview
11.7.3 Nippon Fine Chemical Lipid Contract Manufacturing Introduction
11.7.4 Nippon Fine Chemical Revenue in Lipid Contract Manufacturing Business (2018-2023)
11.7.5 Nippon Fine Chemical Recent Development
11.8 Lipoid
11.8.1 Lipoid Company Detail
11.8.2 Lipoid Business Overview
11.8.3 Lipoid Lipid Contract Manufacturing Introduction
11.8.4 Lipoid Revenue in Lipid Contract Manufacturing Business (2018-2023)
11.8.5 Lipoid Recent Development
11.9 Polymun Scientific
11.9.1 Polymun Scientific Company Detail
11.9.2 Polymun Scientific Business Overview
11.9.3 Polymun Scientific Lipid Contract Manufacturing Introduction
11.9.4 Polymun Scientific Revenue in Lipid Contract Manufacturing Business (2018-2023)
11.9.5 Polymun Scientific Recent Development
11.10 Corden Pharma
11.10.1 Corden Pharma Company Detail
11.10.2 Corden Pharma Business Overview
11.10.3 Corden Pharma Lipid Contract Manufacturing Introduction
11.10.4 Corden Pharma Revenue in Lipid Contract Manufacturing Business (2018-2023)
11.10.5 Corden Pharma Recent Development
11.11 Acuitas Therapeutics
11.11.1 Acuitas Therapeutics Company Detail
11.11.2 Acuitas Therapeutics Business Overview
11.11.3 Acuitas Therapeutics Lipid Contract Manufacturing Introduction
11.11.4 Acuitas Therapeutics Revenue in Lipid Contract Manufacturing Business (2018-2023)
11.11.5 Acuitas Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Precision NanoSystems
Evonik
Merck KGaA
Genevant Sciences
Exelead
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid
Polymun Scientific
Corden Pharma
Acuitas Therapeutics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂